Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial

British Journal of Surgery

Volumn 93, Issue 12, 2006, Pages 1526-1529

  Yoshikawa, T ^a,h   Sasako, M ^b   Sano, T ^b   Nashimoto, A ^c   Kurita, A ^d   Tsujinaka, T ^e   Tanigawa, N ^f   Yamamoto, S ^g  

^a KANAGAWA CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NIIGATA CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^e OSAKA NATIONAL HOSPITAL   (Japan)

^f OSAKA MEDICAL COLLEGE   (Japan)

^g NATIONAL CANCER CENTER   (Japan)

^h Department of Gastrointestinal Surgery ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROSA; STOMACH CANCER;

HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33845403113     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5487     Document Type: Article

References (15)

1. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5(Suppl 1): 5-11.
2. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003; 21(Suppl): 274S-275S.
3. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002; 5: 1-5.
4. Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 1989; 64: 2053-2062.
5. Takahashi S. Study of para-aortic lymph node metastasis of gastric cancer subjected to superextensive lymph node dissection. Nippon Geka Gakkai Zasshi 1990; 91: 29-35.
6. Kitamura M, Arai K, Iwasaki Y. Clinico-pathological studies and problems on para-aortic lymph node dissection - D4 dissection. Nippon Geka Gakkai Zasshi 1996; 97: 302-307.
7. Isozaki H, Okajima K, Fujii K, Nomura E, Izumi N, Mabuchi H et al. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 1999; 46: 549-554.
8. Baba M, Hokita S, Natsugoe S, Miyazono T, Shimada M, Nakano S et al. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 2000; 47: 893-896.
9. Kunisaki C, Shimada H, Yamaoka H, Wakasugi J, Takahashi M, Akiyama H et al. Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 1999; 46: 2635-2642.
10. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma (1st English edn). Kanehara & Co: Tokyo, 1995.
11. Sobin LH, Wittekind C. International Union Against Cancer. TNM Classification of Malignant Tumours (5th edn). Wiley-Liss: New York, 1997.
12. Keighley MRB, Moore J, Roginski C, Powell J, Thompson H. Incidence and prognosis of N4 node involvement in gastric cancer. Br J Surg 1984; 71: 863-866.
13. Gunji Y, Suzuki T, Kobayashi S, Hori S, Hayashi H, Shimada H et al. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer. Hepatogastroenterology 2003; 50: 1178-1182.
14. Bunt AMG, Hermans J, Smit VT, van de Velde CJH, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13: 19-25.
15. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22: 2767-2773.